1. Home /
  2. Medical and health /
  3. Medeor Therapeutics

Category



General Information

Locality: South San Francisco, California



Address: 1 Tower Place, 9th Floor 94402 South San Francisco, CA, US

Website: clinicaltrials.gov/ct2/show/NCT03363945?term=NCT03363945&rank=1

Likes: 10328

Reviews

Add review

Facebook Blog





Medeor Therapeutics 13.11.2020

Are you about to receive a kidney transplant? Medeor is currently enrolling specific living donor and recipient pairs in a unique clinical trial. We are happy to provide the names of participating and soon to be participating hospitals and clinics in order to help you with your transplant journey.

Medeor Therapeutics 26.10.2020

Are you, a family member or a friend considering becoming a living #kidneydonor or about to receive a #kidneytransplant? Learn more about the clinical trial for certain genetically-matched donor-recipient pairs.

Medeor Therapeutics 23.10.2020

We would like your feedback! Have you visited Medeor’s web page www.medeortx.com and used our 'Learn More' link above or spoken to your physician about our kidney transplant clinical trial? Medeor is developing an investigational, single-dose, cell-based therapy intended to reprogram a person’s immune system to accept a transplanted kidney without the need for long-term use of anti-rejection pills and capsules. We are happy to provide the names of participating and soon to be participating hospitals and clinics in order to help you with your transplant journey.

Medeor Therapeutics 17.10.2020

Happy #MothersDay to all the moms out there!

Medeor Therapeutics 06.10.2020

1 in 10 adults worldwide are living with Chronic Kidney Disease. Have you considered a living donor kidney transplant?

Medeor Therapeutics 25.09.2020

Thank you for liking and following Medeor Therapeutics. We would like to help you navigate information regarding living donor kidney transplant, whether you are a potential kidney donor or kidney recipient. We can also address questions that you have about Medeor's investigative products and programs. Please forward any other ideas about what we can do to help you on your journey. Steven R. Deitcher, M.D. President & CEO Medeor Therapeutics

Medeor Therapeutics 12.09.2020

Following FDA review and permission, Medeor is the first company to enter into a Phase 3 clinical trial utilizing cellular immunotherapy for recipients of kidney transplants. Head over to the Xtalk YouTube channel link below to hear more.

Medeor Therapeutics 04.09.2020

Are you, a family member or a friend considering a living donor kidney transplant? Medeor is now enrolling in a clinical trial for certain genetically-matched donor-patient pairs. Click the link below to learn more: https://clinicaltrials.gov/ct2/show/NCT03363945

Medeor Therapeutics 20.08.2020

About 100,000 Americans are awaiting a kidney transplant. Are you, a family member or a friend considering a living donor kidney transplant?